Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
NAS:CUTR's Cash-to-Debt is ranked higher than
98% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.87 vs. NAS:CUTR: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:CUTR' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.61
NAS:CUTR's Equity-to-Asset is ranked higher than
50% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. NAS:CUTR: 0.61 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:CUTR' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27  Med: 0.81 Max: 0.87
Current: 0.61
-0.27
0.87
Interest Coverage No Debt
NAS:CUTR's Interest Coverage is ranked higher than
97% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 71.12 vs. NAS:CUTR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NAS:CUTR' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 11.77
Beneish M-Score: -2.09
WACC vs ROIC
3.30%
129.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 7.75
NAS:CUTR's Operating Margin % is ranked higher than
56% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. NAS:CUTR: 7.75 )
Ranked among companies with meaningful Operating Margin % only.
NAS:CUTR' s Operating Margin % Range Over the Past 10 Years
Min: -20.83  Med: -7.94 Max: 9.39
Current: 7.75
-20.83
9.39
Net Margin % 7.99
NAS:CUTR's Net Margin % is ranked higher than
62% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. NAS:CUTR: 7.99 )
Ranked among companies with meaningful Net Margin % only.
NAS:CUTR' s Net Margin % Range Over the Past 10 Years
Min: -32.93  Med: -7.42 Max: 10.33
Current: 7.99
-32.93
10.33
ROE % 19.24
NAS:CUTR's ROE % is ranked higher than
80% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. NAS:CUTR: 19.24 )
Ranked among companies with meaningful ROE % only.
NAS:CUTR' s ROE % Range Over the Past 10 Years
Min: -16.6  Med: -6.99 Max: 19.24
Current: 19.24
-16.6
19.24
ROA % 12.39
NAS:CUTR's ROA % is ranked higher than
80% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.11 vs. NAS:CUTR: 12.39 )
Ranked among companies with meaningful ROA % only.
NAS:CUTR' s ROA % Range Over the Past 10 Years
Min: -13.66  Med: -5.3 Max: 12.39
Current: 12.39
-13.66
12.39
ROC (Joel Greenblatt) % 125.83
NAS:CUTR's ROC (Joel Greenblatt) % is ranked higher than
92% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.41 vs. NAS:CUTR: 125.83 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:CUTR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1247.08  Med: -223.26 Max: 140.19
Current: 125.83
-1247.08
140.19
3-Year Revenue Growth Rate 18.40
NAS:CUTR's 3-Year Revenue Growth Rate is ranked higher than
82% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. NAS:CUTR: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:CUTR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -18.1  Med: 10.1 Max: 54.9
Current: 18.4
-18.1
54.9
GuruFocus has detected 3 Warning Signs with Cutera Inc NAS:CUTR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:CUTR's 30-Y Financials

Financials (Next Earnings Date: 2018-02-13)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

CUTR Guru Trades in Q4 2016

Discovery Group I, LLC 212,139 sh (+118.26%)
Jim Simons 1,063,260 sh (+1.71%)
Mario Gabelli 605,000 sh (unchged)
» More
Q1 2017

CUTR Guru Trades in Q1 2017

Jim Simons 1,205,400 sh (+13.37%)
Discovery Group I, LLC Sold Out
Mario Gabelli 556,000 sh (-8.10%)
» More
Q2 2017

CUTR Guru Trades in Q2 2017

Mario Gabelli 576,363 sh (+3.66%)
Jim Simons 1,214,500 sh (+0.75%)
» More
Q3 2017

CUTR Guru Trades in Q3 2017

Chuck Royce 122 sh (New)
Mario Gabelli 575,763 sh (-0.10%)
Jim Simons 1,045,680 sh (-13.90%)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2017-09-30 Reduce -0.10%$25.55 - $41.15 $ 42.5030%575,763
Mario Gabelli 2017-06-30 Add 3.66%$19.2 - $26.55 $ 42.5095%576,363
Mario Gabelli 2017-03-31 Reduce -8.10%0.01%$17.45 - $21.9 $ 42.50115%556,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:TCMD, MIL:ELN, NYSE:IVC, NAS:EXAC, NAS:VRAY, ROCO:8406, NAS:AXGN, NYSE:CRY, NAS:GNMK, NAS:ARAY, XKRX:043150, TSE:4549, SZSE:300314, LSE:CSRT, HKSE:01358, LSE:MGP, OHEL:DETEC, HKSE:03600, XKRX:060280, XKRX:054950 » details
Traded in other countries:TJ9.Germany,
Headquarter Location:USA
Cutera Inc is a medical device company. The Company is engaged in designing, development, manufacturing, marketing and servicing of laser and other energy based aesthetics systems for practitioners.

Cutera Inc is a medical device company. The Company is engaged in designing, development, manufacturing, marketing and servicing of laser and other energy based aesthetics systems for practitioners.

Ratios

vs
industry
vs
history
PE Ratio 53.79
CUTR's PE Ratio is ranked lower than
86% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 30.77 vs. CUTR: 53.79 )
Ranked among companies with meaningful PE Ratio only.
CUTR' s PE Ratio Range Over the Past 10 Years
Min: 14.53  Med: 51.9 Max: 343.09
Current: 53.79
14.53
343.09
Forward PE Ratio 35.46
CUTR's Forward PE Ratio is ranked lower than
84% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. CUTR: 35.46 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 53.79
CUTR's PE Ratio without NRI is ranked lower than
86% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.81 vs. CUTR: 53.79 )
Ranked among companies with meaningful PE Ratio without NRI only.
CUTR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.53  Med: 51.9 Max: 343.09
Current: 53.79
14.53
343.09
Price-to-Owner-Earnings 87.66
CUTR's Price-to-Owner-Earnings is ranked lower than
89% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 37.10 vs. CUTR: 87.66 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CUTR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.03  Med: 23.83 Max: 217.87
Current: 87.66
8.03
217.87
PB Ratio 9.68
CUTR's PB Ratio is ranked lower than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. CUTR: 9.68 )
Ranked among companies with meaningful PB Ratio only.
CUTR' s PB Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.57 Max: 10.69
Current: 9.68
0.68
10.69
PS Ratio 4.42
CUTR's PS Ratio is ranked lower than
63% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. CUTR: 4.42 )
Ranked among companies with meaningful PS Ratio only.
CUTR' s PS Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.94 Max: 5.61
Current: 4.42
0.93
5.61
Price-to-Free-Cash-Flow 55.92
CUTR's Price-to-Free-Cash-Flow is ranked lower than
81% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 28.08 vs. CUTR: 55.92 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CUTR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.78  Med: 52.04 Max: 1266
Current: 55.92
9.78
1266
Price-to-Operating-Cash-Flow 52.69
CUTR's Price-to-Operating-Cash-Flow is ranked lower than
89% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. CUTR: 52.69 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CUTR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.28  Med: 42.46 Max: 431.11
Current: 52.69
9.28
431.11
EV-to-EBIT 49.05
CUTR's EV-to-EBIT is ranked lower than
92% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 23.37 vs. CUTR: 49.05 )
Ranked among companies with meaningful EV-to-EBIT only.
CUTR' s EV-to-EBIT Range Over the Past 10 Years
Min: -3233.4  Med: -2.8 Max: 695.7
Current: 49.05
-3233.4
695.7
EV-to-EBITDA 44.97
CUTR's EV-to-EBITDA is ranked lower than
90% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 17.75 vs. CUTR: 44.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
CUTR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -503.2  Med: -2.7 Max: 172.5
Current: 44.97
-503.2
172.5
EV-to-Revenue 3.82
CUTR's EV-to-Revenue is ranked lower than
55% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. CUTR: 3.82 )
Ranked among companies with meaningful EV-to-Revenue only.
CUTR' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.2  Med: 0.8 Max: 6.3
Current: 3.82
-0.2
6.3
Current Ratio 2.63
CUTR's Current Ratio is ranked higher than
52% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. CUTR: 2.63 )
Ranked among companies with meaningful Current Ratio only.
CUTR' s Current Ratio Range Over the Past 10 Years
Min: 2.5  Med: 6.39 Max: 9.09
Current: 2.63
2.5
9.09
Quick Ratio 1.98
CUTR's Quick Ratio is ranked higher than
56% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CUTR: 1.98 )
Ranked among companies with meaningful Quick Ratio only.
CUTR' s Quick Ratio Range Over the Past 10 Years
Min: 1.98  Med: 5.92 Max: 8.66
Current: 1.98
1.98
8.66
Days Inventory 104.95
CUTR's Days Inventory is ranked higher than
67% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 139.39 vs. CUTR: 104.95 )
Ranked among companies with meaningful Days Inventory only.
CUTR' s Days Inventory Range Over the Past 10 Years
Min: 66.49  Med: 104.48 Max: 137.01
Current: 104.95
66.49
137.01
Days Sales Outstanding 50.48
CUTR's Days Sales Outstanding is ranked higher than
80% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 67.97 vs. CUTR: 50.48 )
Ranked among companies with meaningful Days Sales Outstanding only.
CUTR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.62  Med: 40.06 Max: 52.02
Current: 50.48
22.62
52.02
Days Payable 34.71
CUTR's Days Payable is ranked lower than
82% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. CUTR: 34.71 )
Ranked among companies with meaningful Days Payable only.
CUTR' s Days Payable Range Over the Past 10 Years
Min: 17.66  Med: 20.42 Max: 36.15
Current: 34.71
17.66
36.15

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.40
CUTR's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. CUTR: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CUTR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.6  Med: -2.45 Max: 3
Current: 0.4
-13.6
3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 53.80
CUTR's Price-to-Net-Cash is ranked lower than
71% of the 105 Companies
in the Global Medical Devices industry.

( Industry Median: 14.17 vs. CUTR: 53.80 )
Ranked among companies with meaningful Price-to-Net-Cash only.
CUTR' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.66 Max: 59.56
Current: 53.8
1.2
59.56
Price-to-Net-Current-Asset-Value 10.32
CUTR's Price-to-Net-Current-Asset-Value is ranked lower than
63% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 7.13 vs. CUTR: 10.32 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CUTR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.91  Med: 2.02 Max: 23.73
Current: 10.32
0.91
23.73
Price-to-Tangible-Book 9.88
CUTR's Price-to-Tangible-Book is ranked lower than
77% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. CUTR: 9.88 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CUTR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.77  Med: 1.96 Max: 20.68
Current: 9.88
0.77
20.68
Price-to-Intrinsic-Value-Projected-FCF 11.90
CUTR's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
91% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. CUTR: 11.90 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CUTR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.45  Med: 1.86 Max: 1308
Current: 11.9
0.45
1308
Price-to-Median-PS-Value 2.28
CUTR's Price-to-Median-PS-Value is ranked lower than
89% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. CUTR: 2.28 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CUTR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.56  Med: 1.09 Max: 2.72
Current: 2.28
0.56
2.72
Price-to-Graham-Number 4.86
CUTR's Price-to-Graham-Number is ranked lower than
88% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. CUTR: 4.86 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CUTR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.93  Med: 2.21 Max: 7.76
Current: 4.86
0.93
7.76
Earnings Yield (Greenblatt) % 2.05
CUTR's Earnings Yield (Greenblatt) % is ranked higher than
51% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.94 vs. CUTR: 2.05 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CUTR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -224.8  Med: -8 Max: 795.7
Current: 2.05
-224.8
795.7

More Statistics

Revenue (TTM) (Mil) $141.74
EPS (TTM) $ 0.79
Beta0.15
Short Percentage of Float2.28%
52-Week Range $14.05 - 47.15
Shares Outstanding (Mil)13.85

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 147 173 200 229
EPS ($) 0.95 1.20 1.55 1.65
EPS without NRI ($) 0.95 1.20 1.55 1.65
EPS Growth Rate
(Future 3Y To 5Y Estimate)
27.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}